Molecular Diagnostics for Cancer Drug Development

Molecular Diagnostics for Cancer Drug Development is a major conference with a special focus on the decisive molecular diagnostic challenges drawing the future of oncology drug development. This conference is deliberately intended for scientists, oncologists, physicians and business leaders in oncology. It will serve as an opportunity to discover numerous innovative strategies to develop competence around projecting biomarker identification and effectiveness in drug development. The key theme of the conference is “Unleash the True Potential of Your Oncology Pipeline”, which will address a range of relevant topics. Molecular Diagnostics for Cancer Drug Development is the most significant conference covering all facets of biomarker utility across numerous indications.